Lung function testing in infants with cystic fibrosis: lessons from the past and future directions

M Gappa1, S C Ranganathan, J Stocks

  • 1Department of Paediatric Pulmonology and Neonatology, University Children's Hospital, Hannover Medical School, Hannover, Germany. gappa.monika@mh-hannover.de

Pediatric Pulmonology
|September 6, 2001
PubMed

Insights

Lung function testing in infants with cystic fibrosis (CF) is crucial for early detection of pulmonary changes. Standardized multicenter approaches and new techniques can improve diagnostic accuracy in young children with CF.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cystic Fibrosis Research

Background:

  • Early identification of pulmonary changes in cystic fibrosis (CF) is increasingly recognized as vital.
  • The role and interpretation of lung function testing in infants and young children with CF are less established than in older individuals.

Purpose of the Study:

  • To review and synthesize existing data on lung function testing in infants and young children with CF.
  • To contextualize historical findings with recent advancements in lung function assessment for CF patients of all ages.
  • To identify challenges and propose future directions for effective lung function testing in early CF.

Main Methods:

  • Comprehensive literature review of studies on lung function testing in CF, focusing on infancy and early childhood.
  • Analysis of data variability due to differing methodologies, equipment, patient selection, and reference standards across centers.
  • Consideration of emerging techniques like raised volume fluid threshold (RVFT) curves and ventilation inhomogeneity assessment.

Main Results:

  • Existing data has contributed to understanding CF respiratory physiology, but interpretation is often limited.
  • Methodological inconsistencies and lack of standardized reference data hinder the reliable application of lung function tests in infants.
  • Recent developments offer potential for more effective testing in this age group.

Conclusions:

  • Standardized, multicenter approaches are essential for reliable lung function testing in infants with CF.
  • Incorporating advanced techniques such as RVFT curves and ventilation inhomogeneity assessment can enhance diagnostic capabilities.
  • Future research should focus on establishing robust reference data and standardized protocols for early CF lung function assessment.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...